抗流感治疗策略:系统审查和网络元分析
Muayad Saud Albadrani1,2, Amr Molla3, Hossein M Elbadawy4,5
1Department of Family and Community Medicine and Medical Education, College of Medicine, Taibah University, Madinah, 42353, Saudi Arabia. mbadrani@taibahu.edu.sa.
BMC infectious diseases
|May 16, 2025
概括
多次剂量二甲基加阿尔本达 (DA) 有效地减少了六个月和十二个月的淋巴性 filariasis 患者的微血症. 药物组合显示出可比的安全性概况,没有观察到不良事件的显著差异.
科学领域:
- 热带医学 热带医学
- 寄生虫学的寄生虫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 世界卫生组织 (WHO) 建议大规模药物管理 (MDA) 用于消除淋巴状丝腺症 (LF).
- 世界卫生组织在特定地区批准了Ivermectin,diethylcarbamazine和albendazole (IDA) 用于MDA.
- 在撒哈拉以南非洲地区,IDA的使用是有限的,因为甲基碳氨酸对球病患者的潜在严重的眼部不良事件.
研究的目的:
- 对所有已记录的抗流感药物组合进行网络元分析 (NWM),用于治疗LF.
- 为了比较各种药物治疗方案在LF治疗中的疗效和安全性.
主要方法:
- 在四个电子数据库中进行了全面的文献搜索.
- 进行了一个频率网络元分析 (NWM).
- 使用95%置信区间 (CI) 的风险比率 (RRs) 来评估分类结果.
主要成果:
- 该分析包括了45项研究,涉及61369名患者.
- 多重二甲基加阿尔本达 (DA) 剂量在六个月内降低微血症的效果优于单次DA,二甲基,艾弗梅克丁或单独的阿尔本达.
- 伊弗梅克丁加上阿尔本达 (IA) 显示出对单一治疗的显著疗效. DA显示优于单独使用的阿尔本达或安慰剂.
- 在十二个月后,二甲基碳氨酸,其次是阿尔本达,优于IDA和DA. 在24个月后,没有发现小细菌血症减少的显著差异.
- 在研究的药物组合中,没有观察到安全性或不良事件的显著差异.
结论:
- 多个DA剂量在6个月和12个月后在减少小细菌血症方面表现出更高的疗效.
- 在24个月后,没有观察到有效性的显著差异.
- 干预措施的安全性概况相似,没有特定的药物组合在不良事件方面表现出优越性.
更多相关视频
05:28Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
Published on: May 12, 2022
2.7K
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
417
相关概念视频
01:26Pharmaceutical Poisoning: Treatment Strategies
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...